Market Overview

Urstadt Biddle Properties Inc. Announces Increase in Quarterly Dividend to $0.2525 per Share From $0.25


At their regular meeting yesterday, the Directors of Urstadt Biddle Properties Inc. (NYSE: UBA) approved an increase in the quarterly dividend rate declared for its Class A Common stock. The quarterly dividend rate declared for the Class A Common stock was increased to $0.2525 per share, which represents an annualized increase of $0.01 per share for the Class A Common shares. The Board of Directors declared a quarterly dividend for the Common shares of $0.225 per share, unchanged from the prior year. The $0.01 increase on the Class A Common stock dividend represents the twentieth consecutive year that the company has increased total dividends to its shareholders. The Class A Common and Common dividends are payable January 17, 2014 to stockholders of record on January 3, 2014. The dividends declared represent the 176th consecutive quarterly dividend on common shares declared since the Company began operating in 1969.

The Directors of the company also declared the regular quarterly dividends on the Company's Series D Preferred Stock and Series F Preferred Stock. The dividends were declared in the amount of $0.46875 for each share of Series D Preferred Stock and $0.4453125 for each share of Series F Preferred Stock. The dividends are payable January 31, 2014 to stockholders of record on January 17, 2014.

Urstadt Biddle Properties Inc. is a self-administered equity real estate investment trust which owns or has equity interests in 66 properties containing approximately 5.1 million square feet of space. Listed on the New York Stock Exchange since 1970, it provides investors with a means of participating in ownership of income-producing properties. It has paid 176 consecutive quarters of uninterrupted dividends to its shareholders since its inception and has raised total dividends to its shareholders for the last 20 consecutive years.

Posted-In: News Dividends


Related Articles (UBA)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Benzinga Weekly Preview: Markets Anxiously Await Fed Meeting

FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen; Also Approved by European Comission